MyFinsight
Home
Blog
About
Cash and cash
equivalents
$27,015K
(-33.51%↓ Y/Y)
Short-term investments
$4,471K
(-85.64%↓ Y/Y)
Prepaid expenses and
other current assets
$4,201K
(-29.84%↓ Y/Y)
Accounts receivable, net
$2,936K
Total current assets
$38,623K
(-50.33%↓ Y/Y)
Property and equipment,
net
$3,600K
(-11.13%↓ Y/Y)
Other assets
$646K
(1335.56%↑ Y/Y)
Right-of-use lease assets,
net
$561K
(-32.00%↓ Y/Y)
Intangible assets, net
$42K
(-12.50%↓ Y/Y)
Total assets
$43,472K
(-47.45%↓ Y/Y)
Total liabilities and
shareholders' equity
$43,472K
(-47.45%↓ Y/Y)
Total shareholders'
equity
$26,861K
(-62.35%↓ Y/Y)
Total liabilities
$16,611K
(45.93%↑ Y/Y)
Accumulated deficit
-$437,517K
(-18.72%↓ Y/Y)
Accumulated other
comprehensive loss
-$962K
(30.04%↑ Y/Y)
Treasury shares
$180K
(0.00%↑ Y/Y)
Additional paid-in capital
$465,509K
(5.46%↑ Y/Y)
Total current
liabilities
$16,301K
(51.76%↑ Y/Y)
Non-current lease
liabilities
$203K
(-60.96%↓ Y/Y)
Other non-current
liabilities
$107K
(-12.30%↓ Y/Y)
Ordinary shares,
0.000174 par value...
$11K
(10.00%↑ Y/Y)
Accrued liabilities
$13,892K
(75.12%↑ Y/Y)
Accounts payable
$2,016K
(-12.12%↓ Y/Y)
Current lease
liabilities
$393K
(12.29%↑ Y/Y)
Back
Back
Balance Sheet
Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Ltd (CNTB)
source: myfinsight.com